ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 629730 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 629730; 2) Community: the network communities that were significantly associated with the response to NSC 629730; 3) Molecule: the relationships between components within communities and NSC 629730; 4) MDR: the compounds that were significantly associated with the NSC 629730.

NSC Compound Enrichment Correlation
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.00415749398947839 0.48243051
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0041872854493286 0.4641042
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0041872854493286 0.0718173
NSC 606497 Camptothecin Derivative 0.0041872854493286 0.19907348
NSC 642324 Null 0.0041872854493286 0.14516874
NSC 642947 Methanone, [3-(dibromomethyl)-6-chloroquinolin-2-yl] phenyl- 0.0041872854493286 0.26840545
NSC 678040 Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- 0.0041872854493286 0.26273753
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0041872854493286 0.1807607
NSC 692332 Null 0.0041872854493286 0.40229234
NSC 692574 Null 0.0041872854493286 0.34127134
Total:128  Current:11    [First] [Prev] [Next] [Last]